[{"address1": "830 Winter Street", "city": "Waltham", "state": "MA", "zip": "02451", "country": "United States", "phone": "781 999 0232", "website": "https://www.q32bio.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Q32 Bio Inc., a clinical-stage biotechnology company, develops novel biologics to restore healthy immune balance in patients with autoimmune and inflammatory diseases driven by pathological immune dysfunction. The company is developing Bempikibart (ADX-914), a fully human anti\u0096interleukin-7 receptor alpha antagonist monoclonal antibody designed to re-regulate adaptive immune function by blocking signaling mediated by interleukin-7 and thymic stromal lymphopoietin for the treatment of atopic dermatitis and alopecia areata. It also develops ADX-096, a C3d mAb \u0096 CR1 fusion protein for use in ophthalmologic indications, as well as other C3d mAb fusions and nanobodies designed for tissue-targeted complement inhibition. The company was founded in 2017 and is based in Waltham, Massachusetts.", "fullTimeEmployees": 27, "companyOfficers": [{"maxAge": 1, "name": "Ms. Jodie Pope Morrison", "age": 48, "title": "CEO & Director", "yearBorn": 1976, "fiscalYear": 2024, "totalPay": 860740, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Lee H. Kalowski M.B.A.", "age": 43, "title": "CFO & President", "yearBorn": 1981, "fiscalYear": 2024, "totalPay": 750793, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Shelia M. Violette Ph.D.", "age": 63, "title": "Co-founder, Chief Scientific Officer & President of Research", "yearBorn": 1961, "fiscalYear": 2024, "totalPay": 619930, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Saul W. Fink Ph.D.", "title": "Chief Technology Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. David  Appugliese J.D.", "title": "Senior VP & Head of People", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Maria  Marzilli M.P.H.", "title": "Executive Vice President of Corporate Strategy & Program Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Adrien  Sipos", "title": "Interim Chief Medical Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 2.32, "open": 2.28, "dayLow": 2.15, "dayHigh": 2.3, "regularMarketPreviousClose": 2.32, "regularMarketOpen": 2.28, "regularMarketDayLow": 2.15, "regularMarketDayHigh": 2.3, "payoutRatio": 0.0, "forwardPE": -0.42164177, "volume": 93799, "regularMarketVolume": 93799, "averageVolume": 232000, "averageVolume10days": 94280, "averageDailyVolume10Day": 94280, "bid": 2.58, "ask": 2.35, "bidSize": 1, "askSize": 1, "marketCap": 27566610, "fiftyTwoWeekLow": 1.345, "fiftyTwoWeekHigh": 47.465, "allTimeHigh": 572.4, "allTimeLow": 1.345, "fiftyDayAverage": 2.3816, "twoHundredDayAverage": 2.1108, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -8568390, "profitMargins": 0.0, "floatShares": 5388418, "sharesOutstanding": 12197615, "sharesShort": 464505, "sharesShortPriorMonth": 288476, "sharesShortPreviousMonthDate": 1757894400, "dateShortInterest": 1760486400, "sharesPercentSharesOut": 0.0381, "heldPercentInsiders": 0.065409996, "heldPercentInstitutions": 0.69693, "shortRatio": 1.07, "shortPercentOfFloat": 0.1353, "impliedSharesOutstanding": 12197615, "bookValue": -1.003, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -52304000, "trailingEps": -4.34, "forwardEps": -5.36, "lastSplitFactor": "1:18", "lastSplitDate": 1711411200, "enterpriseToEbitda": 0.158, "52WeekChange": -0.9497889, "SandP52WeekChange": 0.12121439, "quoteType": "EQUITY", "currentPrice": 2.26, "targetHighPrice": 20.0, "targetLowPrice": 6.0, "targetMeanPrice": 12.0, "targetMedianPrice": 10.0, "recommendationKey": "none", "numberOfAnalystOpinions": 3, "totalCash": 54832000, "totalCashPerShare": 4.495, "ebitda": -54287000, "totalDebt": 18697000, "quickRatio": 4.802, "currentRatio": 5.057, "returnOnAssets": -0.35952, "returnOnEquity": -4.91671, "grossProfits": -48145000, "freeCashflow": -36647500, "operatingCashflow": -54083000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "QTTB", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "CLOSED", "longName": "Q32 Bio Inc.", "fiftyDayAverageChange": -0.12159991, "fiftyDayAverageChangePercent": -0.051058076, "twoHundredDayAverageChange": 0.14919996, "twoHundredDayAverageChangePercent": 0.07068408, "priceToBook": -2.25324, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "corporateActions": [], "postMarketTime": 1762561027, "regularMarketTime": 1762549200, "exchange": "NCM", "messageBoardId": "finmb_669405676", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1522243800000, "postMarketChangePercent": 6.194695, "postMarketPrice": 2.4, "postMarketChange": 0.1400001, "regularMarketChange": -0.0599999, "regularMarketDayRange": "2.15 - 2.3", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 232000, "fiftyTwoWeekLowChange": 0.91499996, "fiftyTwoWeekLowChangePercent": 0.6802974, "fiftyTwoWeekRange": "1.345 - 47.465", "fiftyTwoWeekHighChange": -45.205, "fiftyTwoWeekHighChangePercent": -0.952386, "fiftyTwoWeekChangePercent": -94.97889, "earningsTimestampStart": 1762432200, "earningsTimestampEnd": 1762432200, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -4.34, "epsForward": -5.36, "regularMarketChangePercent": -2.5862, "regularMarketPrice": 2.26, "shortName": "Q32 Bio Inc.", "displayName": "Q32 Bio", "trailingPegRatio": null, "__fetch_time": "2025-11-08"}]